Hidemoto Saiki

Nagakute, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Hyperthyroidism Can Precipitate Peak-Dose Levodopa-Induced Dyskinesia in Parkinson's Disease.

Hyperthyroidism Can Precipitate Peak-Dose Levodopa-Induced Dyskinesia in Parkinson's Disease.

Journal: Movement disorders clinical practice
Published: November 09, 2025

Inward Lead Migration Years After Pallidal Deep Brain Stimulation.

Inward Lead Migration Years After Pallidal Deep Brain Stimulation.

Journal: Movement disorders clinical practice
Published: September 04, 2025

Cortical Ribboning as a Key MRI Finding in Wernicke's Encephalopathy With Altered Mental Status.

Cortical Ribboning as a Key MRI Finding in Wernicke's Encephalopathy With Altered Mental Status.

Journal: Cureus
Published: February 19, 2025

Therapeutic Strategy for Improving Motor Complications of Parkinson's Disease: Short-Term Levodopa-Carbidopa Intestinal Gel Therapy Using a Nasogastric Tube.

Therapeutic Strategy for Improving Motor Complications of Parkinson's Disease: Short-Term Levodopa-Carbidopa Intestinal Gel Therapy Using a Nasogastric Tube.

Journal: Journal of movement disorders
Published: February 08, 2024

Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.

Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.

Journal: PloS one
Published: January 29, 2024

Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST.

Risk factors for developing dyskinesia among Parkinson's disease patients with wearing-off: J-FIRST.

Journal: Journal of the neurological sciences
Published: November 07, 2022

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.

Journal: Journal of Parkinson's disease
Published: December 13, 2021

Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST).

Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST).

Journal: Parkinsonism & related disorders
Published: April 11, 2021

Japanese Familial Cases of Frontotemporal Dementia and Parkinsonism with N279K Tau Gene Mutation.

Japanese Familial Cases of Frontotemporal Dementia and Parkinsonism with N279K Tau Gene Mutation.

Journal: Movement disorders clinical practice
Published: July 04, 2020

Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study.

Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study.

Journal: Journal of the neurological sciences
Published: June 24, 2019

Mutations in CHCHD2 cause α-synuclein aggregation.

Mutations in CHCHD2 cause α-synuclein aggregation.

Journal: Human molecular genetics
Published: May 30, 2019

Real-World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J-FIRST.

Real-World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J-FIRST.

Journal: Movement disorders clinical practice
Published: April 30, 2019
Showing 1-12 of 20

Last Updated: 09/26/2026